IBDEI2UE ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47699,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Remission
 ;;^UTILITY(U,$J,358.3,47699,1,4,0)
 ;;=4^C94.41
 ;;^UTILITY(U,$J,358.3,47699,2)
 ;;=^5001844
 ;;^UTILITY(U,$J,358.3,47700,0)
 ;;=C94.42^^209^2346^29
 ;;^UTILITY(U,$J,358.3,47700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47700,1,3,0)
 ;;=3^Acute Panmyelosis w/ Myelofibrosis,In Relapse
 ;;^UTILITY(U,$J,358.3,47700,1,4,0)
 ;;=4^C94.42
 ;;^UTILITY(U,$J,358.3,47700,2)
 ;;=^5001845
 ;;^UTILITY(U,$J,358.3,47701,0)
 ;;=C94.6^^209^2346^362
 ;;^UTILITY(U,$J,358.3,47701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47701,1,3,0)
 ;;=3^Myelodysplastic Disease NEC
 ;;^UTILITY(U,$J,358.3,47701,1,4,0)
 ;;=4^C94.6
 ;;^UTILITY(U,$J,358.3,47701,2)
 ;;=^5001846
 ;;^UTILITY(U,$J,358.3,47702,0)
 ;;=C94.80^^209^2346^244
 ;;^UTILITY(U,$J,358.3,47702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47702,1,3,0)
 ;;=3^Leukemias NEC,Not in Remission
 ;;^UTILITY(U,$J,358.3,47702,1,4,0)
 ;;=4^C94.80
 ;;^UTILITY(U,$J,358.3,47702,2)
 ;;=^5001847
 ;;^UTILITY(U,$J,358.3,47703,0)
 ;;=C94.81^^209^2346^243
 ;;^UTILITY(U,$J,358.3,47703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47703,1,3,0)
 ;;=3^Leukemias NEC,In Remission
 ;;^UTILITY(U,$J,358.3,47703,1,4,0)
 ;;=4^C94.81
 ;;^UTILITY(U,$J,358.3,47703,2)
 ;;=^5001848
 ;;^UTILITY(U,$J,358.3,47704,0)
 ;;=C94.82^^209^2346^242
 ;;^UTILITY(U,$J,358.3,47704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47704,1,3,0)
 ;;=3^Leukemias NEC,In Relapse
 ;;^UTILITY(U,$J,358.3,47704,1,4,0)
 ;;=4^C94.82
 ;;^UTILITY(U,$J,358.3,47704,2)
 ;;=^5001849
 ;;^UTILITY(U,$J,358.3,47705,0)
 ;;=C95.00^^209^2346^6
 ;;^UTILITY(U,$J,358.3,47705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47705,1,3,0)
 ;;=3^Acute Leukemia,Unspec Cell Type,Not in Remission
 ;;^UTILITY(U,$J,358.3,47705,1,4,0)
 ;;=4^C95.00
 ;;^UTILITY(U,$J,358.3,47705,2)
 ;;=^5001850
 ;;^UTILITY(U,$J,358.3,47706,0)
 ;;=C95.01^^209^2346^5
 ;;^UTILITY(U,$J,358.3,47706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47706,1,3,0)
 ;;=3^Acute Leukemia,Unspec Cell Type,In Remission
 ;;^UTILITY(U,$J,358.3,47706,1,4,0)
 ;;=4^C95.01
 ;;^UTILITY(U,$J,358.3,47706,2)
 ;;=^5001851
 ;;^UTILITY(U,$J,358.3,47707,0)
 ;;=C95.02^^209^2346^4
 ;;^UTILITY(U,$J,358.3,47707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47707,1,3,0)
 ;;=3^Acute Leukemia,Unspec Cell Type,In Relapse
 ;;^UTILITY(U,$J,358.3,47707,1,4,0)
 ;;=4^C95.02
 ;;^UTILITY(U,$J,358.3,47707,2)
 ;;=^5001852
 ;;^UTILITY(U,$J,358.3,47708,0)
 ;;=C95.10^^209^2346^81
 ;;^UTILITY(U,$J,358.3,47708,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47708,1,3,0)
 ;;=3^Chronic Leukemia,Unspec Cell Type,Not in Remission
 ;;^UTILITY(U,$J,358.3,47708,1,4,0)
 ;;=4^C95.10
 ;;^UTILITY(U,$J,358.3,47708,2)
 ;;=^5001853
 ;;^UTILITY(U,$J,358.3,47709,0)
 ;;=C95.11^^209^2346^79
 ;;^UTILITY(U,$J,358.3,47709,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47709,1,3,0)
 ;;=3^Chronic Leukemia,Unspec Cell Type,In Remission
 ;;^UTILITY(U,$J,358.3,47709,1,4,0)
 ;;=4^C95.11
 ;;^UTILITY(U,$J,358.3,47709,2)
 ;;=^5001854
 ;;^UTILITY(U,$J,358.3,47710,0)
 ;;=C95.12^^209^2346^80
 ;;^UTILITY(U,$J,358.3,47710,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47710,1,3,0)
 ;;=3^Chronic Leukemia,Unspec Cell Type,In Relapse
 ;;^UTILITY(U,$J,358.3,47710,1,4,0)
 ;;=4^C95.12
 ;;^UTILITY(U,$J,358.3,47710,2)
 ;;=^5001855
 ;;^UTILITY(U,$J,358.3,47711,0)
 ;;=C95.90^^209^2346^241
 ;;^UTILITY(U,$J,358.3,47711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47711,1,3,0)
 ;;=3^Leukemia,Unspec,Not in Remission
 ;;^UTILITY(U,$J,358.3,47711,1,4,0)
 ;;=4^C95.90
 ;;^UTILITY(U,$J,358.3,47711,2)
 ;;=^5001856
